Hosted on MSN19h
China’s CDE approves Alphamab’s IND to begin Phase I/II trial of JSKN033
Center for Drug Evaluation (CDE) has approved Alphamab Oncology’s investigational new drug application (IND) for the ...
Hosted on MSN3d
XBiotech halts all rheumatology research after missing Phase II endpoints
The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding ...
MMO Bomb9d
Ashes Of Creation To Kick Off Phase II Of Alpha Two
On Friday, December 20, Intrepid Studios will launch Phase II of Alpha Two for its MMORPG Ashes of Creation. In addition to ...
BioSpace8d
Vertex Dips on Mixed Phase II Data for Non-Opioid Pain Therapy
Vertex Pharmaceuticals’ investigational non-opioid analgesic suzetrigine failed to outperform placebo. Investors voiced their ...
Taiwan News2d
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved
JSKN033-102 is an open-label, multicenter, Phase â… /â…¡ clinical study designed to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics and anti-tumor activity of JSKN033 in patients with ...
The Financial Express1d
Max Estates reports pre-sales booking worth Rs 845 crore within a week of Phase II Estate 128 project launch in Noida
Combining both phases, the Estate 128 community will now comprise 4 towers with 268 units, spanning 10 acres and a total ...
Max Estates registers Rs 845 crore in pre-sales bookings from phase II of Noida project
Max Estates COO Rishi Raj said the company is confident of adding 'at least 3 million sq. ft. every year' to the current portfolio, and diversifying in Delhi NCR across commercial and residential ...